PTX-35
PTX-35 is a human IgG monoclonal antibody (mAb) targeting TNFRSF25. PTX-35 reduces the suppressive activity of regulatory T cells and enhances CD4+ T cell effector responses in a mouse melanoma model. PTX-35 can be used in Islet cell transplant rejection and Solid tumours research. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) [1].
Product Specifications
UNSPSC
12352203
Target
TNF Receptor
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[3H][P][F,Cl,Br,I]
References & Citations
[1]Kalim K W, et al. PTX-35, a potential first-in-class TNFRSF25 agonist, reduced the suppressive activity of regulatory T cells and enhanced CD4+ T cell effector responses, in the presence of tumor antigens, in a murine melanoma model[J]. Cancer Research, 2021, 81 (13_Supplement) : 604-604.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1081009-01 0.02 mg (E-Coli)
Recombinant Campylobacter concisus Bifunctional protein GlmU (glmU)
Ask
View Details 
MBS1081009-02 0.02 mg (Yeast)
Recombinant Campylobacter concisus Bifunctional protein GlmU (glmU)
Ask
View Details 
MBS1081009-03 0.1 mg (E-Coli)
Recombinant Campylobacter concisus Bifunctional protein GlmU (glmU)
Ask
View Details 
MBS1081009-04 0.1 mg (Yeast)
Recombinant Campylobacter concisus Bifunctional protein GlmU (glmU)
Ask
View Details MBS1081009-05 0.02 mg (Baculovirus)
Recombinant Campylobacter concisus Bifunctional protein GlmU (glmU)
Ask
View Details MBS1081009-06 0.02 mg (Mammalian-Cell)
Recombinant Campylobacter concisus Bifunctional protein GlmU (glmU)
Ask
View Details